Skip to main content

Advertisement

SpringerLink
Log in

Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Oropharynx and Nasopharynx

  • Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors
  • Published:
Head and Neck Pathology Aims and scope Submit manuscript

Abstract

The new WHO classification of head and neck tumors provides a comprehensive overview of lesions by summarizing their clinical, epidemiological, histological, immunohistochemical, molecular and genetic features. The chapters related to the description of oropharyngeal and nasopharyngeal lesions have thus been largely modified.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Data Availability

Not applicable.

Code Availability

Not applicable.

References

  1. El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ, editors. WHO classification of head and neck tumours. 4th ed. Lyon: International Agency for Research on Cancer; 2017.

    Google Scholar 

  2. WHO Classification of Tumours Editorial Board. WHO classification of tumours series. Head and neck tumours. 5th ed., vol. 9. Lyon: International Agency for Research on Cancer; 2022.

  3. Fossum CC, Chintakuntlawar AV, Price DL, Garcia JJ. Characterization of the oropharynx: anatomy, histology, immunology, squamous cell carcinoma and surgical resection. Histopathology. 2017;70:1021–9. https://doi.org/10.1111/his.13140.

    Article  PubMed  Google Scholar 

  4. Kardon DE, Wenig BM, Heffner DK, Thompson LDR. Tonsillar lymphangiomatous polyps: a clinicopathologic series of 26 cases. Mod Pathol. 2000;13:1128–33.

    CAS  PubMed  Google Scholar 

  5. Barreto I, Costa AF, Martins MT, Furuse C, de Araújo VC, Altemani A. Immunohistochemical study of stromal and vascular components of tonsillar polyps: high endothelial venules as participants of the polyp’s lymphoid tissue. Virchows Arch. 2011;459:65–71. https://doi.org/10.1007/s00428-011-1088-8.

    Article  CAS  PubMed  Google Scholar 

  6. Min HJ, Kim KS. Lymphangiomatous polyp arising from the palatine tonsil. Ear Nose Throat J. 2021;100:NP154–5. https://doi.org/10.1177/0145561319863367.

    Article  PubMed  Google Scholar 

  7. International Agency for Research on Cancer. WHO Global Cancer Observatory. Lyon: International Agency for Research on Cancer; 2020.

    Google Scholar 

  8. Shield KD, Ferlay J, Jemal A, Sankaranarayanan R, Chaturvedi AK, Bray F, et al. The global incidence of lip, oral cavity, and pharyngeal cancers by subsite in 2012. CA Cancer J Clin. 2017;67:51–64. https://doi.org/10.3322/caac.21384.

    Article  PubMed  Google Scholar 

  9. Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W, Kim E, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol. 2011;29:4294–301. https://doi.org/10.1200/JCO.2011.36.4596.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tân PF, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010;363:24–35.

    CAS  PubMed  PubMed Central  Google Scholar 

  11. Wotman M, Oh EJ, Ahn S, Kraus D, Costantino P, Tham T. HPV status in patients with nasopharyngeal carcinoma in the United States: a SEER database study. Am J Otolaryngol. 2019;40:705–10.

    PubMed  Google Scholar 

  12. Verma V, Simone CB, Lin C. Human papillomavirus and nasopharyngeal cancer. Head Neck. 2018;40:696–706. https://doi.org/10.1002/hed.24978.

    Article  PubMed  Google Scholar 

  13. Castellsagué X, Alemany L, Quer M, Halec G, Quirós B, Tous S, et al. HPV involvement in head and neck cancers: comprehensive assessment of biomarkers in 3680 patients. J Natl Cancer Inst. 2016;108:div403.

    Google Scholar 

  14. Lam EWH, Chan JYW, Chan ABW, Ng CS, Lo STH, Lam VSC, et al. Prevalence, clinicopathological characteristics, and outcome of human papillomavirus-associated oropharyngeal cancer in Southern Chinese Patients. Cancer Epidemiol Biomark Prev. 2016;25:165–73. https://doi.org/10.1158/1055-9965.EPI-15-0869.

    Article  Google Scholar 

  15. Shaikh MH, Khan AI, Sadat A, Chowdhury AH, Jinnah SA, Gopalan V, et al. Prevalence and types of high-risk human papillomaviruses in head and neck cancers from Bangladesh. BMC Cancer. 2017;17:792. https://doi.org/10.1186/s12885-017-3789-0.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Lim MY, Dahlstrom KR, Sturgis EM, Li G. Human papillomavirus integration pattern and demographic, clinical, and survival characteristics of patients with oropharyngeal squamous cell carcinoma. Head Neck. 2016;38:1139–44. https://doi.org/10.1002/hed.24429.

    Article  PubMed  Google Scholar 

  17. Augustin J, Mandavit M, Outh-Gauer S, Grard O, Gasne C, Lépine C, et al. HPV RNA CISH score identifies two prognostic groups in a p16 positive oropharyngeal squamous cell carcinoma population. Mod Pathol. 2018;31:1645–52.

    CAS  PubMed  Google Scholar 

  18. Drake VE, Fakhry C, Windon MJ, Stewart CM, Akst L, Hillel A, et al. Timing, number, and type of sexual partners associated with risk of oropharyngeal cancer. Cancer. 2021;127:1029–38.

    CAS  PubMed  Google Scholar 

  19. Fakhry C, Waterboer T, Westra WH, Rooper LM, Windon M, Troy T, et al. Distinct biomarker and behavioral profiles of human papillomavirus-related oropharynx cancer patients by age. Oral Oncol. 2020;101:104522.

    CAS  PubMed  Google Scholar 

  20. Roberts S, Evans D, Mehanna H, Parish JL. Modelling human papillomavirus biology in oropharyngeal keratinocytes. Philos Trans R Soc B Biol Sci. 2019;374:20180289. https://doi.org/10.1098/rstb.2018.0289.

    Article  CAS  Google Scholar 

  21. Westra WH. The morphologic profile of HPV-related head and neck squamous carcinoma: implications for diagnosis, prognosis, and clinical management. Head Neck Pathol. 2012;6:48–54. https://doi.org/10.1007/s12105-012-0371-6.

    Article  PubMed Central  Google Scholar 

  22. Perry ME. The specialised structure of crypt epithelium in the human palatine tonsil and its functional significance. J Anat. 1994;185(Pt 1):111–27.

    PubMed  PubMed Central  Google Scholar 

  23. Kranjec C, Holleywood C, Libert D, Griffin H, Mahmood R, Isaacson E, et al. Modulation of basal cell fate during productive and transforming HPV-16 infection is mediated by progressive E6-driven depletion of Notch. J Pathol. 2017;242:448–62. https://doi.org/10.1002/path.4917.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Lyford-Pike S, Peng S, Young GD, Taube JM, Westra WH, Akpeng B, et al. Evidence for a role of the PD-1:PD-L1 pathway in immune resistance of HPV-associated head and neck squamous cell carcinoma. Cancer Res. 2013;73:1733–41.

    CAS  PubMed  PubMed Central  Google Scholar 

  25. Bishop JA, Westra WH. Ciliated HPV-related carcinoma: a well-differentiated form of head and neck carcinoma that can be mistaken for a benign cyst. Am J Surg Pathol. 2015;39:1591–5.

    PubMed  PubMed Central  Google Scholar 

  26. Alos L, Hakim S, Larque A-B, de la Oliva J, Rodriguez-Carunchio L, Caballero M, et al. p16 overexpression in high-grade neuroendocrine carcinomas of the head and neck: potential diagnostic pitfall with HPV-related carcinomas. Virchows Arch. 2016;469:277–84. https://doi.org/10.1007/s00428-016-1982-1.

    Article  CAS  PubMed  Google Scholar 

  27. Bates T, McQueen A, Iqbal MS, Kelly C, Robinson M. Small cell neuroendocrine carcinoma of the oropharynx harbouring oncogenic HPV-infection. Head Neck Pathol. 2014;8:127–31. https://doi.org/10.1007/s12105-013-0471-y.

    Article  PubMed  Google Scholar 

  28. Hojilla CV, Yu ES, Perez-Ordonez B. Human papillomavirus-associated poorly differentiated (small cell) neuroendocrine carcinoma of the oropharynx. Diagnos Histopathol. 2013;19:20–4.

    Google Scholar 

  29. Bishop JA, Westra WH. Human papillomavirus-related small cell carcinoma of the oropharynx. Am J Surg Pathol. 2011;35:1679–84.

    PubMed  PubMed Central  Google Scholar 

  30. Kraft S, Faquin WC, Krane JF. HPV-associated Neuroendocrine carcinoma of the oropharynx. Am J Surg Pathol. 2012;36:321–30.

    PubMed  Google Scholar 

  31. Thompson ED, Stelow EB, Mills SE, Westra WH, Bishop JA. Large cell neuroendocrine carcinoma of the head and neck. Am J Surg Pathol. 2016;40:471–8.

    PubMed  PubMed Central  Google Scholar 

  32. D’Souza G, Kreimer AR, Viscidi R, Pawlita M, Fakhry C, Koch WM, et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med. 2007;356:1944–56. https://doi.org/10.1056/nejmoa065497.

    Article  PubMed  Google Scholar 

  33. Würdemann N, Wagner S, Sharma SJ, Prigge E-S, Reuschenbach M, Gattenlöhner S, et al. Prognostic impact of AJCC/UICC 8th editon new staging rules in oropharyngeal squamous cell carcinoma. Front Oncol. 2017. https://doi.org/10.3389/fonc.2017.00129/full.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Goldenberg D, Begum S, Westra WH, Khan Z, Sciubba J, Pai SI, et al. Cystic lymph node metastasis in patients with head and neck cancer: an HPV-associated phenomenon. Head Neck. 2008;30:898–903. https://doi.org/10.1002/hed.20796.

    Article  PubMed  Google Scholar 

  35. Yasui T, Morii E, Yamamoto Y, Yoshii T, Takenaka Y, Nakahara S, et al. Human papillomavirus and cystic node metastasis in oropharyngeal cancer and cancer of unknown primary origin. PLoS ONE. 2014;9:e95364. https://doi.org/10.1371/journal.pone.0095364.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Morani AC, Eisbruch A, Carey TE, Hauff SJ, Walline HM, Mukherji SK. Intranodal cystic changes. J Comput Assist Tomogr. 2013;37:343–5.

    PubMed  PubMed Central  Google Scholar 

  37. An Y, Park HS, Kelly JR, Stahl JM, Yarbrough WG, Burtness BA, et al. The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma. Cancer. 2017;123:2762–72.

    CAS  PubMed  Google Scholar 

  38. Day AT, Yang AM, Tanamal P, Blackwell J-M, Wang E, Sumer BD, et al. Extracapsular extension, pathologic node status, and adjuvant treatment in primary surgery patients with human papillomavirus-mediated oropharyngeal cancer: National hospital-based retrospective cohort analysis. Head Neck. 2021;43:3345–63.

    PubMed  Google Scholar 

  39. Martinez-Zapien D, Ruiz FX, Poirson J, Mitschler A, Ramirez J, Forster A, et al. Structure of the E6/E6AP/p53 complex required for HPV-mediated degradation of p53. Nature. 2016;529:541–5.

    CAS  PubMed  PubMed Central  Google Scholar 

  40. Hoppe-Seyler K, Bossler F, Braun JA, Herrmann AL, Hoppe-Seyler F. The HPV E6/E7 oncogenes: key factors for viral carcinogenesis and therapeutic targets. Trends Microbiol. 2018;26:158–68.

    CAS  PubMed  Google Scholar 

  41. Augustin JG, Lepine C, Morini A, Brunet A, Veyer D, Brochard C, et al. HPV detection in head and neck squamous cell carcinomas: what is the issue? Front Oncol. 2020. https://doi.org/10.3389/fonc.2020.01751/full.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Lewis JS, Beadle B, Bishop JA, Chernock RD, Colasacco C, Lacchetti C, et al. Human papillomavirus testing in head and neck carcinomas: guideline from the college of american pathologists. Arch Pathol Lab Med. 2018;142:559–97.

    PubMed  Google Scholar 

  43. McLaughlin-Drubin ME, Crum CP, Münger K. Human papillomavirus E7 oncoprotein induces KDM6A and KDM6B histone demethylase expression and causes epigenetic reprogramming. Proc Natl Acad Sci USA. 2011;108:2130–5. https://doi.org/10.1073/pnas.1009933108.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Nauta IH, Rietbergen MM, van Bokhoven AAJD, Bloemena E, Lissenberg-Witte BI, Heideman DAM, et al. Evaluation of the eighth TNM classification on p16-positive oropharyngeal squamous cell carcinomas in the Netherlands and the importance of additional HPV DNA testing. Ann Oncol. 2018;29:1273–9.

    CAS  PubMed  Google Scholar 

  45. Mehanna H, Evans M, Beasley M, Chatterjee S, Dilkes M, Homer J, et al. Oropharyngeal cancer: United Kingdom National Multidisciplinary Guidelines. J Laryngol Otol. 2016;130:S90–6.

    CAS  PubMed  PubMed Central  Google Scholar 

  46. Fakhry C, Lacchetti C, Perez-Ordonez B. Human papillomavirus testing in head and neck carcinomas: ASCO clinical practice guideline endorsement summary of the CAP guideline. J Oncol Pract. 2018;14:613–7. https://doi.org/10.1200/JOP.18.00433.

    Article  PubMed  Google Scholar 

  47. El-Naggar AK, Westra WH. p16 expression as a surrogate marker for HPV-related oropharyngeal carcinoma: a guide for interpretative relevance and consistency. Head Neck. 2012;34:459–61. https://doi.org/10.1002/hed.21974.

    Article  PubMed  Google Scholar 

  48. Lawrence MS, Stojanov P, Polak P, Kryukov GV, Cibulskis K, Sivachenko A, et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature. 2013;499:214–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  49. Seiwert TY, Zuo Z, Keck MK, Khattri A, Pedamallu CS, Stricker T, et al. Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas. Clin Cancer Res. 2015;21:632–41.

    CAS  PubMed  Google Scholar 

  50. Feldman R, Gatalica Z, Knezetic J, Reddy S, Nathan C-A, Javadi N, et al. Molecular profiling of head and neck squamous cell carcinoma. Head Neck. 2016;38(Suppl 1):E1625-1638.

    PubMed  Google Scholar 

  51. Misiukiewicz K, Gupta V, Miles BA, Bakst R, Genden E, Selkridge I, et al. Standard of care vs reduced-dose chemoradiation after induction chemotherapy in HPV+ oropharyngeal carcinoma patients: the Quarterback trial. Oral Oncol. 2019;95:170–7.

    CAS  PubMed  Google Scholar 

  52. Wang MB, Liu IY, Gornbein JA, Nguyen CT. HPV-positive oropharyngeal carcinoma. Otolaryngol Neck Surg. 2015;153:758–69. https://doi.org/10.1177/0194599815592157.

    Article  Google Scholar 

  53. Lydiatt WM, Patel SG, O’Sullivan B, Brandwein MS, Ridge JA, Migliacci JC, et al. Head and Neck cancers-major changes in the American Joint Committee on cancer eighth edition cancer staging manual. CA Cancer J Clin. 2017;67:122–37.

    PubMed  Google Scholar 

  54. Lewis JS, Adelstein DJ, Agaimy A, Carlson DL, Faquin WC, Helliwell T, et al. Data set for the reporting of carcinomas of the nasopharynx and oropharynx: explanations and recommendations of the guidelines from the international collaboration on cancer reporting. Arch Pathol Lab Med. 2019;143:447–51.

    CAS  PubMed  Google Scholar 

  55. Howard J, Dwivedi RC, Masterson L, Kothari P, Quon H, Holsinger FC. De-intensified adjuvant (chemo)radiotherapy versus standard adjuvant chemoradiotherapy post transoral minimally invasive surgery for resectable HPV-positive oropharyngeal carcinoma. Cochrane Database Syst Rev. 2018. https://doi.org/10.1002/14651858.CD012939.pub2.

    Article  PubMed  PubMed Central  Google Scholar 

  56. Khariwala SS, Hatsukami D, Hecht SS. Tobacco carcinogen metabolites and DNA adducts as biomarkers in Head and Neck cancer: potential screening tools and prognostic indicators. Head Neck. 2012;34:441–7. https://doi.org/10.1002/hed.21705.

    Article  PubMed  Google Scholar 

  57. Seitz HK, Stickel F. Risk factors and mechanisms of hepatocarcinogenesis with special emphasis on alcohol and oxidative stress. Biol Chem. 2006. https://doi.org/10.1515/BC.2006.047/html.

    Article  PubMed  Google Scholar 

  58. Seitz HK, Stickel F. Molecular mechanisms of alcohol-mediated carcinogenesis. Nat Rev Cancer. 2007;7:599–612.

    CAS  PubMed  Google Scholar 

  59. Gormley M, Dudding T, Sanderson E, Martin RM, Thomas S, Tyrrell J, et al. A multivariable Mendelian randomization analysis investigating smoking and alcohol consumption in oral and oropharyngeal cancer. Nat Commun. 2020;11:6071.

    CAS  PubMed  PubMed Central  Google Scholar 

  60. Tramacere I, Negri E, Bagnardi V, Garavello W, Rota M, Scotti L, et al. A meta-analysis of alcohol drinking and oral and pharyngeal cancers. Part 1: overall results and dose-risk relation. Oral Oncol. 2010;46:497–503.

    PubMed  Google Scholar 

  61. Kim HAJ, Zeng PYF, Shaikh MH, Mundi N, Ghasemi F, Di Gravio E, et al. All HPV-negative head and neck cancers are not the same: analysis of the TCGA dataset reveals that anatomical sites have distinct mutation, transcriptome, hypoxia, and tumor microenvironment profiles. Oral Oncol. 2021;116:105260.

    CAS  PubMed  Google Scholar 

  62. Outh-Gauer S, Morini A, Tartour E, Lépine C, Jung AC, Badoual C. The microenvironment of head and neck cancers: papillomavirus involvement and potential impact of immunomodulatory treatments. Head Neck Pathol. 2020;14:330–40. https://doi.org/10.1007/s12105-020-01147-x.

    Article  PubMed  PubMed Central  Google Scholar 

  63. Bishop JA, Montgomery EA, Westra WH. Use of p40 and p63 immunohistochemistry and human papillomavirus testing as ancillary tools for the recognition of head and neck sarcomatoid carcinoma and its distinction from benign and malignant mesenchymal processes. Am J Surg Pathol. 2014;38:257–64.

    PubMed  PubMed Central  Google Scholar 

  64. Tse E, Kwong Y-L. NK/T-cell lymphomas. Best Pract Res Clin Haematol. 2019;32:253–61.

    PubMed  Google Scholar 

  65. Cone BM, Taweevisit M, Shenoda S, Sobol S, Schemankewitz E, Shehata BM. Pharyngeal hairy polyps: five new cases and review of the literature. Fetal Pediatr Pathol. 2012;31:184–9. https://doi.org/10.3109/15513815.2011.648722.

    Article  PubMed  Google Scholar 

  66. Melzer JM, Morgan A, Darrow D. Congenital choristoma (Hairy Polyp) of the Eustachian tube: surgical management of a rare clinical entity. Ear Nose Throat J. 2016;95:E43–5. https://doi.org/10.1177/014556131609500106.

    Article  PubMed  Google Scholar 

  67. Herrmann BW, Dehner LP, Lieu JEC. Congenital salivary gland anlage tumor: a case series and review of the literature. Int J Pediatr Otorhinolaryngol. 2005;69:149–56.

    PubMed  Google Scholar 

  68. Peters SM, Turk AT. Salivary gland anlage tumor: molecular profiling sheds light on a morphologic question. Oral Surg Oral Med Oral Pathol Oral Radiol. 2019;127:e108–13.

    PubMed  Google Scholar 

  69. Lai Y, Li W, Zhai C, Song X, Yang J, Sun X, et al. Low-grade nasopharyngeal papillary adenocarcinoma: a review of 28 patients in a Single Institution. Cancer Manage Res. 2021;13:1271–8.

    CAS  Google Scholar 

  70. Pineda-Daboin K, Neto A, Ochoa-Perez V, Luna MA. Nasopharyngeal adenocarcinomas: a clinicopathologic study of 44 cases including immunohistochemical features of 18 papillary phenotypes. Ann Diagn Pathol. 2006;10:215–21.

    PubMed  Google Scholar 

  71. Thompson LDR. Nasopharyngeal papillary adenocarcinoma. Ear Nose Throat J. 2017;96:456–7. https://doi.org/10.1177/014556131709601203.

    Article  PubMed  Google Scholar 

  72. Yu MC, Yuan J-M. Epidemiology of nasopharyngeal carcinoma. Semin Cancer Biol. 2002;12:421–9.

    PubMed  Google Scholar 

  73. Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, et al. Global cancer observatory: cancer today. Lyon: International Agency for Research on Cancer; 2020.

    Google Scholar 

  74. Bray F, Colombet M, Mery L, Piñeros M, Znaor A, Zanetti R, et al. Cancer incidence in Five Continents, vol. XI. Lyon: International Lyon; 2017.

    Google Scholar 

  75. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424. https://doi.org/10.3322/caac.21492.

    Article  PubMed  Google Scholar 

  76. Huang WB, Chan JYW, Liu DL. Human papillomavirus and World Health Organization type III nasopharyngeal carcinoma: multicenter study from an endemic area in Southern China. Cancer. 2018;124:530–6. https://doi.org/10.1002/cncr.31031.

    Article  PubMed  Google Scholar 

  77. Augustin J, Outh-Gauer S, Mandavit M, Gasne C, Grard O, Denize T, et al. Evaluation of the efficacy of the 4 tests (p16 immunochemistry, polymerase chain reaction, DNA, and RNA in situ hybridization) to evaluate a human papillomavirus infection in head and neck cancers: a cohort of 348 French squamous cell carcinomas. Hum Pathol. 2018;78:63–71.

    CAS  PubMed  Google Scholar 

  78. Lin Z, Khong B, Kwok S, Cao H, West RB, Le Q-T, et al. Human papillomavirus 16 detected in nasopharyngeal carcinomas in white Americans but not in endemic Southern Chinese patients. Head Neck. 2014;36:709–14. https://doi.org/10.1002/hed.23362.

    Article  PubMed  Google Scholar 

  79. O’Sullivan B, Brierley JD, D’Cruz A, Fey M, Pollock RE, Vermorken J, et al. Nasopharynx. UICC Manual of Clinical Oncology. 9th ed. 2015. p. 512–23.

  80. Pan JJ, Ng WT, Zong JF, Chan LLK, O’Sullivan B, Lin SJ, et al. Proposal for the 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapy. Cancer. 2016;122:546–58. https://doi.org/10.1002/cncr.29795.

    Article  PubMed  Google Scholar 

  81. Yang X-L, Wang Y, Liang S-B, He S-S, Chen D-M, Chen H-Y, et al. Comparison of the seventh and eighth editions of the UICC/AJCC staging system for nasopharyngeal carcinoma: analysis of 1317 patients treated with intensity-modulated radiotherapy at two centers. BMC Cancer. 2018;18:606. https://doi.org/10.1186/s12885-018-4419-1.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  82. Chua DTT, Nicholls JM, Sham JST, Au GKH. Prognostic value of epidermal growth factor receptor expression in patients with advanced stage nasopharyngeal carcinoma treated with induction chemotherapy and radiotherapy. Int J Radiat Oncol Biol Phys. 2004;59:11–20.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

Viktoria Nagy, Sophie Outh-Gauer, Michel Wassef, Aurore Coulomb-Lhermine, Valérie Costes.

Funding

Not applicable.

Author information

Authors and Affiliations

  1. Service d’Anatomo-Pathologie, Department of Pathology, Hôpital Européen G Pompidou, APHP, Université de Paris, 20-40 rue Leblanc, 75015, Paris, France

    Cécile Badoual

Authors
  1. Cécile Badoual
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Conceptualization, literature search, data analysis, writing, review and editing by CB.

Corresponding author

Correspondence to Cécile Badoual.

Ethics declarations

Conflict of interest

The author declares that there is no conflict of interest relative to tis research project.

Ethical Approval

This review article did not involve the use of human or animal subjects and has complied with the ethical standards as outlined by the publisher.

Consent to Participate

Not applicable.

Consent for Publication

The author has read and agreed to the published version of the manuscript.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Badoual, C. Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Oropharynx and Nasopharynx. Head and Neck Pathol 16, 19–30 (2022). https://doi.org/10.1007/s12105-022-01449-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12105-022-01449-2

Keywords

Search

Navigation